Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Eli Lilly CEO Dave Ricks on Wednesday promised not to raise prices on the company's existing insulin products again — the only executive to do so before a Senate Health Committee hearing on making the life-saving diabetes drug more…